Several studies have identified the expression of RasGRP3 on different malignant cancer types, but in this study we show for the first time that RasGRP3 is overexpressed in human breast cancer samples as well as in multiple breast cancer derived cell lines. Here, RASGRP3 is linked to breast cancer.